| Atomoxetine Azure 80 mg hard capsules PA22871/034/006 |
Atomoxetine hydrochloride |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Atorvastatin Bluefish 10 mg Film-coated tablets PA1436/027/001 |
Atorvastatin calcium trihydrate |
Bluefish Pharmaceuticals AB |
Marketed |
| Atorvastatin Bluefish 20 mg Film-coated tablets PA1436/027/002 |
Atorvastatin calcium trihydrate |
Bluefish Pharmaceuticals AB |
Marketed |
| Atorvastatin Bluefish 30 mg Film-coated tablets PA1436/027/003 |
Atorvastatin calcium trihydrate |
Bluefish Pharmaceuticals AB |
Marketed |
| Atorvastatin Bluefish 40 mg Film-coated tablets PA1436/027/004 |
Atorvastatin calcium trihydrate |
Bluefish Pharmaceuticals AB |
Marketed |
| Atorvastatin Bluefish 60 mg Film-coated tablets PA1436/027/005 |
Atorvastatin calcium trihydrate |
Bluefish Pharmaceuticals AB |
Marketed |
| Atorvastatin Bluefish 80 mg Film-coated tablets PA1436/027/006 |
Atorvastatin calcium trihydrate |
Bluefish Pharmaceuticals AB |
Marketed |
| Atorvastatin Rowa 10 mg film-coated tablets PA0074/079/001 |
Atorvastatin |
Rowa Pharmaceuticals Limited, |
Marketed |
| Atorvastatin Rowa 20 mg film-coated tablets PA0074/079/002 |
Atorvastatin |
Rowa Pharmaceuticals Limited, |
Marketed |
| Atorvastatin Rowa 40 mg film-coated tablets PA0074/079/003 |
Atorvastatin |
Rowa Pharmaceuticals Limited, |
Marketed |
| Atorvastatin Rowa 80 mg film-coated tablets PA0074/079/004 |
Atorvastatin |
Rowa Pharmaceuticals Limited, |
Marketed |
| ATRIANCE 5mg/ml Solution for Infusion EU/1/07/403/001 |
Nelarabine |
Sandoz Pharmaceuticals d.d. |
— |
| Axura 10 mg film-coated tablets EU/1/02/218/1-3 |
Memantine hydrochloride |
Merz Pharmaceuticals GmbH |
— |
| Axura 20 mg film-coated tablets EU/1/02/218/17-22 |
Memantine |
Merz Pharmaceuticals GmbH |
— |
| Axura 5 mg+10 mg+15 mg+20 mg film-coated tablets EU/1/02/218/16 |
Memantine |
Merz Pharmaceuticals GmbH |
— |
| Axura 5 mg/pump actuation oral solution EU/1/02/218/5-6 |
Memantine hydrochloride |
Merz Pharmaceuticals GmbH |
— |
| Azacitidine Mylan 25 mg/mL powder for suspension for injection EU/1/20/1426/001-002 |
Azacitidine |
Mylan Pharmaceuticals Limited |
— |
| Azactam 1 g Powder for Solution for Injection or Infusion PA1418/021/001 |
Aztreonam |
Athlone Pharmaceuticals Limited |
Marketed |
| Azactam 2 g Powder for Solution for Injection or Infusion PA1418/021/002 |
Aztreonam |
Athlone Pharmaceuticals Limited |
Marketed |
| Azuzote 30 mg film-coated tablets PA22871/001/001 |
Nefopam hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| Baqsimi 3 mg nasal powder in single-dose container EU/1/19/1406/001-002 |
GLUCAGON |
Amphastar France Pharmaceuticals, S.A.S. |
— |
| Besremi 250 micogram/0.5 ml Solution for injection in pre-filled pen EU/1/18/1352/001 |
Ropeginterferon alfa-2b |
Aop Orphan Pharmaceuticals GmbH |
— |
| Besremi 500 microgram/0.5 ml Solution for injection in pre-filled pen EU/1/18/1352/002 |
Ropeginterferon alfa-2b |
Aop Orphan Pharmaceuticals GmbH |
— |
| Betahistine dihydrochloride 16 mg Tablets PA22871/017/002 |
Betahistine dihydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| Betahistine dihydrochloride 24 mg Tablets PA22871/017/003 |
Betahistine dihydrochloride |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Betahistine dihydrochloride 8 mg Tablets PA22871/017/001 |
Betahistine dihydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| Betnesol 0.1% w/v Eye, Ear and Nasal Drops, solution PA1638/001/001 |
BETAMETHASONE SODIUM PHOSPHATE |
RPH Pharmaceuticals AB |
Marketed |
| Betnesol-N 0.1% w/v, 3500 IU/ml Eye, Ear and Nasal Drops, solution PA1638/002/001 |
Neomycin sulfate, BETAMETHASONE SODIUM PHOSPHATE |
RPH Pharmaceuticals AB |
Marketed |
| Bettamousse 1 mg/g (0.1%) cutaneous foam PA1638/009/001 |
Betamethasone valerate |
RPH Pharmaceuticals AB |
Marketed |
| BOCOUTURE 100 units powder for solution for injection PA1907/003/002 |
CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS |
Merz Pharmaceuticals GmbH |
Marketed |
| BOCOUTURE 50 units powder for solution for injection PA1907/003/001 |
CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS |
Merz Pharmaceuticals GmbH |
Marketed |
| Bonasol Once Weekly 70 mg Oral Solution PA1572/001/001 |
Alendronate sodium trihydrate |
Xeolas Pharmaceuticals Limited |
Marketed |
| Briumvi 150 mg Concentrate for solution for infusion EU/1/23/1730/001 |
Ublituximab |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Brupro 200mg Film-coated tablets PA0074/067/001 |
Ibuprofen |
Rowa Pharmaceuticals Limited, |
Marketed |
| Brupro Cold & Flu 200 mg/30 mg film-coated tablets PA0074/067/006 |
Ibuprofen, PSEUDOEPHEDRINE HYDROCHLORIDE |
Rowa Pharmaceuticals Limited, |
Marketed |
| Brupro for Children 100 mg/5 ml oral suspension PA0074/067/004 |
Ibuprofen |
Rowa Pharmaceuticals Limited, |
Marketed |
| Brupro for Children Six Plus 200 mg/5 ml oral suspension PA0074/067/005 |
Ibuprofen |
Rowa Pharmaceuticals Limited, |
Marketed |
| Brupro Max 400mg Film-coated tablets PA0074/067/002 |
Ibuprofen |
Rowa Pharmaceuticals Limited |
Marketed |
| Brupro Rx 600mg Film-coated tablets PA0074/067/003 |
Ibuprofen |
Rowa Pharmaceuticals Limited |
Not marketed |
| Budesonide Azure 0.5 mg/2 ml Nebuliser Suspension PA22871/035/001 |
Budesonide |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Budesonide Azure 1 mg/2 ml Nebuliser Suspension PA22871/035/002 |
Budesonide |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Bupivacaine Hydrochloride 0.25% w/v Solution for Injection PA0073/091/001 |
Bupivacaine hydrochloride |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Bupivacaine Hydrochloride 0.5% w/v Solution for Injection PA0073/091/002 |
Bupivacaine hydrochloride |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Buprenorphine 0.4 mg Sublingual Tablets PA1567/001/001 |
Buprenorphine hydrochloride |
Activase Pharmaceuticals Limited |
Not marketed |
| Buprenorphine 2 mg Sublingual Tablets PA1567/001/002 |
Buprenorphine hydrochloride |
Activase Pharmaceuticals Limited |
Not marketed |
| Buprenorphine 8 mg Sublingual Tablets PA1567/001/003 |
Buprenorphine hydrochloride |
Activase Pharmaceuticals Limited |
Not marketed |
| BuTrans 10 micrograms/hour transdermal patch PA1688/002/002 |
Buprenorphine |
Mundipharma Pharmaceuticals Limited |
Marketed |
| BuTrans 15 microgram/hour transdermal patch PA1688/002/004 |
Buprenorphine |
Mundipharma Pharmaceuticals Limited |
Marketed |
| BuTrans 20 micrograms/hour transdermal patch PA1688/002/003 |
Buprenorphine |
Mundipharma Pharmaceuticals Limited |
Marketed |
| BuTrans 5 micrograms/hour transdermal patch PA1688/002/001 |
Buprenorphine |
Mundipharma Pharmaceuticals Limited |
Marketed |